These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 1963579)

  • 41. Glycoproteins of axonal transport: affinity chromatography on fucose-specific lectins.
    Gustavsson S; Ohlson C; Karlsson JO
    J Neurochem; 1982 Mar; 38(3):852-5. PubMed ID: 6173468
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Phase II study of 5'-DFUR in uterine cervical cancer and ovarian cancer].
    Noda K; Ikeda M; Saito Y; Yajima A; Sato A; Suzuki M; Terashima Y; Ochiai K; Yoshida K; Takada M
    Gan To Kagaku Ryoho; 1991 Dec; 18(15):2557-65. PubMed ID: 1660700
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A multiwell lectin-binding assay using lotus tetragonolobus for measuring different glycosylated forms of haptoglobin.
    Thompson S; Stappenbeck R; Turner GA
    Clin Chim Acta; 1989 Apr; 180(3):277-84. PubMed ID: 2743580
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mucinous ovarian cancer: A therapeutic review.
    Xu W; Rush J; Rickett K; Coward JI
    Crit Rev Oncol Hematol; 2016 Jun; 102():26-36. PubMed ID: 27083591
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Combined chemotherapy of ovarian cancer with special reference to carboquone].
    Sugimori H; Kidera Y; Matsuyama T
    Gan To Kagaku Ryoho; 1982 Jan; 9(1):66-71. PubMed ID: 6307172
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical characteristics and prognosis of mucinous tumors of the ovary.
    Kikkawa F; Nawa A; Kajiyama H; Shibata K; Ino K; Nomura S
    Gynecol Oncol; 2006 Oct; 103(1):171-5. PubMed ID: 16546243
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Elevated serum 8-OHdG is associated with poor prognosis in epithelial ovarian cancer.
    Pylväs M; Puistola U; Laatio L; Kauppila S; Karihtala P
    Anticancer Res; 2011 Apr; 31(4):1411-5. PubMed ID: 21508394
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Activity of chemotherapy in mucinous epithelial ovarian cancer: a retrospective study.
    Pisano C; Greggi S; Tambaro R; Losito S; Iodice F; Di Maio M; Ferrari E; Falanga M; Formato R; Iaffaioli VR; Pignata S
    Anticancer Res; 2005; 25(5):3501-5. PubMed ID: 16101169
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Treatment of epithelial ovarian carcinoma with cisplatin and adriamycin: analysis of factors influencing prognosis in advanced cases].
    Kamura T; Tsukamoto N; Jo S; Imachi M; Kaku T; Matsukuma K; Matsuyama T
    Gan To Kagaku Ryoho; 1986 Oct; 13(10):2954-9. PubMed ID: 3021066
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Expression and mutation of p53 in tumor effusion cells of patients with ovarian carcinoma: response to cisplatin-based chemotherapy.
    Bar JK; Harłozińska A; Popiela A; Noga L
    Tumour Biol; 2001; 22(2):83-91. PubMed ID: 11125280
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Distribution of fucosyl-conjugates in rat cerebellar cells in vitro: binding patterns of Lotus tetragonolobus and Ulex europeus lectins.
    Minier LN; Erickson PF; Lasher RS
    Brain Res; 1982 May; 256(1):13-21. PubMed ID: 7093726
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Serum fibrinogen/fibrin degradation products in patients with ovarian carcinoma.
    Lalos O; Frankendal B; Rudolphi O
    Ann Chir Gynaecol; 1977; 66(3):131-134. PubMed ID: 327909
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Impact of neoadjuvant chemotherapy cycles prior to interval surgery in patients with advanced epithelial ovarian cancer.
    Colombo PE; Labaki M; Fabbro M; Bertrand M; Mourregot A; Gutowski M; Saint-Aubert B; Quenet F; Rouanet P; Mollevi C
    Gynecol Oncol; 2014 Nov; 135(2):223-30. PubMed ID: 25220627
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A phase II study of combination chemotherapy using docetaxel and irinotecan for TC-refractory or TC-resistant ovarian carcinomas (GOGO-OV2 study) and for primary clear or mucinous ovarian carcinomas (GOGO-OV3 Study).
    Ueda Y; Miyatake T; Nagamatsu M; Yamasaki M; Nishio Y; Yoshino K; Fujita M; Tsutsui T; Enomoto T; Kimura T
    Eur J Obstet Gynecol Reprod Biol; 2013 Sep; 170(1):259-63. PubMed ID: 23880598
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Nursing of a patient with ovarian cancer undergoing postoperative chemotherapy].
    Taguchi A; Nakane N; Watanabe M; Matsumoto S; Nakamura M
    Kango Gijutsu; 1989 Mar; 35(4):400-3. PubMed ID: 2754874
    [No Abstract]   [Full Text] [Related]  

  • 56. Immunological reactivity of mucinous and serous ovarian adenocarcinomas.
    Harłozińska-Szmyrka A; Slesak B; Richter R; Rabczyński J; Cisło M
    Cancer Detect Prev; 1986; 9(3-4):347-58. PubMed ID: 3017557
    [TBL] [Abstract][Full Text] [Related]  

  • 57. What is the benefit of bevacizumab combined with chemotherapy in patients with recurrent ovarian, fallopian tube or primary peritoneal malignancies?
    Cheng X; Moroney JW; Levenback CF; Fu S; Jaishuen A; Kavanagh JJ
    J Chemother; 2009 Nov; 21(5):566-72. PubMed ID: 19933049
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long-term survival rates with various chemotherapeutic regimens in stages III and IV ovarian adenocarcinoma. The influence of optimum pretreatment surgical resection.
    Barlow JJ; Lele SB; Emrich LJ
    Am J Obstet Gynecol; 1985 Jun; 152(3):310-4. PubMed ID: 2988337
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Chemotherapy versus surgery for initial treatment in advanced ovarian epithelial cancer.
    Morrison J; Swanton A; Collins S; Kehoe S
    Cochrane Database Syst Rev; 2007 Oct; (4):CD005343. PubMed ID: 17943850
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [High doses of alkylating agents and bone marrow autograft in ovarian cancer with poor prognosis: a retrospective analysis of 40 patients treated in France].
    Maraninchi D; Viens P; Legros M; Oberling F; Philip T; Herve P; Plagne R; Dufour P; Bergerat JP; Guastalla JP
    Bull Cancer; 1990; 77(2):149-57. PubMed ID: 2156587
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.